A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Clinical trial NCT03617536 · COMPLETED
Trial details
- NCT number
- NCT03617536
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-05
- Primary completion
- 2019-10-24
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.